Cytokine Balance in Human Malaria: Does Plasmodium vivax Elicit More Inflammatory Responses than Plasmodium falciparum?

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Gonçalves, Raquel M ^a   Scopel, Kézia K G ^a,b   Bastos, Melissa S ^a   Ferreira, Marcelo U ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE PLUS PRIMAQUINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADOLESCENT; ADULT; ARTICLE; BRAZILIAN; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALARIA; MALE; OUTCOME ASSESSMENT; PARASITE CLEARANCE; PARASITE LOAD; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SCHOOL CHILD; SPECIES DIFFERENCE;

ADOLESCENT; ADULT; AGED; BLOOD CELL COUNT; BRAZIL; CYTOKINES; HEMOGLOBINS; HUMANS; INFLAMMATION; MALARIA; MIDDLE AGED; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR; STATISTICS, NONPARAMETRIC;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 84866041604     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044394     Document Type: Article

References (52)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434: 214-217.
2. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, et al. (2010) The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4: e774.
3. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, et al. (2009) Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555-566.
4. Anstey NM, Russell B, Yeo TW, Price RN, (2009) The pathophysiology of vivax malaria. Trends Parasitol 25: 220-227.
5. Carvalho BO, Lopes SC, Nogueira PA, Orlandi PP, Bargieri DY, et al. (2010) On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis 202: 638-647.
6. Anstey NM, Handojo T, Pain MC, Kenangalem E, Tjitra E, et al. (2007) Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis 195: 589-596.
7. Price RN, Douglas NM, Anstey NM, (2009) New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis 22: 430-435.
8. Alexandre MA, Ferreira CO, Siqueira AM, Magalhães BL, Mourão MP, et al. (2010) Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis 16: 1611-1614.
9. Langhorne J, Albano FR, Hensmann M, Sanni L, Cadman E, et al. (2004) Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol Rev 201: 35-47.
10. Kremsner PG, Winkler S, Brandts C, Wildling E, Jenne L, et al. (1995) Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am J Trop Med Hyg 53: 532-538.
11. Walther M, Woodruff J, Edele F, Jeffries D, Tongren JE, et al. (2006) Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J Immunol 177: 5736-5745.
12. D'Ombrain MC, Robinson LJ, Stanisic DI, Taraika J, Bernard N, et al. (2008) Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. Clin Infect Dis 47: 1380-1387.
13. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, et al. (1999) The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis 180: 1288-1297.
14. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, et al. (1999) A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 179: 279-282.
15. Perkins DJ, Weinberg JB, Kremsner PG, (2000) Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. J Infect Dis 182: 988-992.
16. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, et al. (2002) Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis 185: 971-979.
17. Kern P, Hemmer CJ, Gallati H, Neifer S, Kremsner P, et al. (1992) Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis 166: 930-934.
18. Akanmori BD, Kurtzhals JA, Goka BQ, Adabayeri V, Ofori MF, et al. (2000) Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur Cytokine Netw 11: 113-118.
19. Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, et al. (2008) Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J 7: 83.
20. Kern P, Kern WV, Kremsner P, (1993) Soluble tumor necrosis factor receptors in Plasmodium vivax malaria. J Infect Dis 168: 1340-1341.
21. Hemmer CJ, Holst FG, Kern P, Chiwakata CB, Dietrich M, et al. (2006) Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health 11: 817-823.
22. Yeo TW, Lampah DA, Tjitra E, Piera K, Gitawati R, et al. (2010) Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia. J Infect Dis 202: 109-112.
23. Gonçalves RM, Salmazi KC, Santos BA, Bastos MS, Rocha SC, et al. (2010) CD4+ CD25+ Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses? Infect Immun 78: 4763-4772.
24. Andrade BB, Reis-Filho A, Souza-Neto SM, Clarêncio J, Camargo LM, et al. (2010) Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar J 13: 9-13.
25. da Silva-Nunes M, Codeço CT, Malafronte RS, da Silva NS, Juncansen C, et al. (2008) Malaria on the Amazonian frontier: transmission dynamics, risk factors, spatial distribution, and prospects for control. Am J Trop Med Hyg 79: 624-635.
26. da Silva NS, da Silva-Nunes M, Malafronte RS, Menezes MJ, D'Arcadia RR, et al. (2010) Epidemiology and control of frontier malaria in Brazil: lessons from community-based studies in rural Amazonia. Trans R Soc Trop Med Hyg 104: 343-350.
27. da Silva-Nunes M, Moreno M, Conn JE, Gamboa D, Abeles S, et al. (2012) Amazonian malaria: Asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. Acta Trop 121: 281-291.
28. Karunaweera ND, Carter R, Grau GE, Mendis K, (1998) Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease. Am J Trop Med Hyg 58: 204-210.
29. da Silva-Nunes M, Ferreira MU, (2007) Clinical spectrum of uncomplicated malaria in semi-immune Amazonians: beyond the "symptomatic" vs "asymptomatic" dichotomy. Mem Inst Oswaldo Cruz 102: 341-347.
30. Filmer D, Pritchett LH, (2001) Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. Demography 38: 115-132.
31. Mayxay M, Pukrittayakamee S, Newton PN, White NJ, (2004) Mixed-species malaria infections in humans. Trends Parasitol 20: 233-240.
32. McKenzie FE, Smith DL, O'Meara WP, Forney JR, Magill AJ, et al. (2006) Fever in patients with mixed-species malaria. Clin Infect Dis 42: 1713-1718.
33. Fernandes AAM, Carvalho LJM, Zanini GM, Ventura AM, Souza JM, et al. (2008) Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivaxiInfections in the Brazilian Amazon region. Clin Vaccine Immunol 15: 650-658.
34. Cox-Singh J, Singh B, Daneshvar C, Planche T, Parker-Williams J, et al. (2011) Anti-inflammatory cytokines predominate in acute human Plasmodium knowlesi infections. PLoS One 6: e20541.
35. Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, et al. (2008) IL-10 from CD4+CD25-Foxp3-CD127- adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog 4: e1000004.
36. Jain V, Singh PP, Silawat N, Patel R, Saxena A, et al. (2010) A preliminary study on pro- and anti-inflammatory cytokine profiles in Plasmodium vivax malaria patients from central zone of India. Acta Trop 113: 263-268.
37. Rodríguez-Morales AJ, Sánchez E, Vargas M, Piccolo C, Colina R, et al. (2005) Occurrence of thrombocytopenia in Plasmodium vivax malaria. Clin Infect Dis 41: 130-131.
38. Lacerda MVG, Mourão MPG, Coelho HCC, Santos JB, (2011) Thrombocytopenia in malaria: who cares? Mem Inst Oswaldo Cruz 106: 52-63.
39. Zeyrek FY, Kurcer MA, Zeyrek D, Simsek Z, (2006) Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey. Parasite Immunol 28: 201-207.
40. Medina TS, Costa SP, Oliveira MD, Ventura AM, Souza JM, et al. (2011) Increased interleukin-10 and interferon-γ levels in Plasmodium vivax malaria suggest a reciprocal regulation which is not altered by IL-10 gene promoter polymorphism. Malar J 10: 264.
41. Deloron P, Roux Lombard P, Ringwald P, Wallon M, Niyongabo T, et al. (1994) Plasma levels of TNF-alpha soluble receptors correlate with outcome in human falciparum malaria. Eur Cytokine Netw 5: 331-336.
42. Thévenon AD, Zhou JA, Megnekou R, Ako S, Leke RG, et al. (2010) Elevated levels of soluble TNF receptors 1 and 2 correlate with Plasmodium falciparum parasitemia in pregnant women: potential markers for malaria-associated inflammation. J Immunol 185: 7115-7122.
43. Freitas do Rosario AP, Lamb T, Spencer P, Stephens R, Lang A, et al. (2012) IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol 188: 1178-1190.
44. Hugosson E, Montgomery SM, Premji Z, Troye-Blomberg M, Björkman A, (2004) Higher IL-10 levels are associated with less effective clearance of Plasmodium falciparum parasites. Parasite Immunol 26: 111-117.
45. Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN, Carter R, (2003) The paroxysm of Plasmodium vivax malaria. Trends Parasitol 19: 188-193.
46. Aderka D, (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7: 231-240.
47. Grell M, (1995) Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J Inflamm 47: 8-17.
48. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, et al. (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol. 151: 1548-1561.
49. Andrade BB, Barral-Netto M, (2011) Biomarkers for susceptibility to infection and disease severity in human malaria. Mem Inst Oswaldo Cruz 106: 70-78.
50. Omer FM, de Souza JB, Riley EM, (2003) Differential induction of TGF-beta regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections. J Immunol 171: 5430-5436.
51. Andrade BB, Araújo-Santos T, Luz NF, Khouri R, Bozza MT, et al. (2010) Heme impairs prostaglandin E2 and TGF-beta production by human mononuclear cells via Cu/Zn superoxide dismutase: insight into the pathogenesis of severe malaria. J Immunol 185: 1196-1204.
52. Andrade BB, Reis-Filho A, Souza-Neto SM, Raffaele-Netto I, Camargo LM, et al. (2010) Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. PLoS Negl Trop Dis 4: e650.